How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.
|Articles|November 15, 2018
- November 2018 Cough, Cold, & Flu
- Volume 84
- Issue 11
Pet Peeves (November 2018)
Read about this month's pet peeves.
Advertisement
CRANKSGIVING
Patients who are unusually rude when they come in during our Thanksgiving hours…trust me, I don’t want to be there any more than they do!
DRIVE-THRU MISUSE
When patients ask for items like candy and soda at the drive-thru.
SLOW-ACTING MEDICAL PRACTICE
Doctors who take hours to get back to us regarding a simple clarifying question.
GAME OF PHONES
When patients get angry at us over the phone because we put them on hold in order to help all of the patients who called before them.
Articles in this issue
almost 8 years ago
Estrogens and Lamotrigine: New Developmentsalmost 8 years ago
From Sea to Shining Sea Pertussis Outbreaks Across the Nationalmost 8 years ago
Iron Products Need Improved Labelingalmost 8 years ago
Florida Pharmacy Owner: "They Call Me First"almost 8 years ago
Chronic Cough: Differential Diagnosesalmost 8 years ago
Should We Believe Patients With Pain?almost 8 years ago
Understanding Naloxone Standing Orders Is VitalAdvertisement
Related to this article
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.
Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pneumonic Plague: What Pharmacists Need to Know About Treatment
2
Could Cemdisiran Keep Patients With Myasthenia Gravis Out of the Hospital?
3
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
4
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
5